GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TiumBio Co Ltd (XKRX:321550) » Definitions » Beneish M-Score

TiumBio Co (XKRX:321550) Beneish M-Score : -3.07 (As of Apr. 23, 2025)


View and export this data going back to 2019. Start your Free Trial

What is TiumBio Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.07 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for TiumBio Co's Beneish M-Score or its related term are showing as below:

XKRX:321550' s Beneish M-Score Range Over the Past 10 Years
Min: -3.07   Med: -2.55   Max: 138.01
Current: -3.07

During the past 8 years, the highest Beneish M-Score of TiumBio Co was 138.01. The lowest was -3.07. And the median was -2.55.


TiumBio Co Beneish M-Score Historical Data

The historical data trend for TiumBio Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TiumBio Co Beneish M-Score Chart

TiumBio Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beneish M-Score
Get a 7-Day Free Trial - - 138.01 -2.55 -3.07

TiumBio Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.55 -0.23 0.63 -1.66 -3.07

Competitive Comparison of TiumBio Co's Beneish M-Score

For the Biotechnology subindustry, TiumBio Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TiumBio Co's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TiumBio Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where TiumBio Co's Beneish M-Score falls into.


;
;

TiumBio Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of TiumBio Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.7043+0.528 * 1+0.404 * 0.1267+0.892 * 1.3865+0.115 * 0.9178
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8788+4.679 * -0.046745-0.327 * 1.3264
=-3.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Total Receivables was ₩2,319 Mil.
Revenue was 1482.261 + 1131.771 + 2186.471 + 1991.732 = ₩6,792 Mil.
Gross Profit was 1482.261 + 1131.771 + 2186.471 + 1991.732 = ₩6,792 Mil.
Total Current Assets was ₩58,914 Mil.
Total Assets was ₩107,298 Mil.
Property, Plant and Equipment(Net PPE) was ₩44,721 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩3,799 Mil.
Selling, General, & Admin. Expense(SGA) was ₩7,120 Mil.
Total Current Liabilities was ₩39,340 Mil.
Long-Term Debt & Capital Lease Obligation was ₩16,680 Mil.
Net Income was 3662.544 + -4195.84 + -12684.032 + -7426.355 = ₩-20,644 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ₩0 Mil.
Cash Flow from Operations was -1805.456 + -3981.324 + -3448.187 + -6393.066 = ₩-15,628 Mil.
Total Receivables was ₩2,374 Mil.
Revenue was 2360.719 + 1370.588 + 967.288 + 200.18 = ₩4,899 Mil.
Gross Profit was 2360.719 + 1370.588 + 967.288 + 200.18 = ₩4,899 Mil.
Total Current Assets was ₩45,311 Mil.
Total Assets was ₩119,546 Mil.
Property, Plant and Equipment(Net PPE) was ₩42,031 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩3,254 Mil.
Selling, General, & Admin. Expense(SGA) was ₩5,843 Mil.
Total Current Liabilities was ₩23,820 Mil.
Long-Term Debt & Capital Lease Obligation was ₩23,235 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2318.63 / 6792.235) / (2374.318 / 4898.775)
=0.341365 / 0.484676
=0.7043

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(4898.775 / 4898.775) / (6792.235 / 6792.235)
=1 / 1
=1

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (58914.024 + 44720.711) / 107298.482) / (1 - (45310.767 + 42030.897) / 119546.025)
=0.034145 / 0.269389
=0.1267

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=6792.235 / 4898.775
=1.3865

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(3253.85 / (3253.85 + 42030.897)) / (3798.55 / (3798.55 + 44720.711))
=0.071853 / 0.07829
=0.9178

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(7120.217 / 6792.235) / (5843.429 / 4898.775)
=1.048288 / 1.192835
=0.8788

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((16680.158 + 39340.084) / 107298.482) / ((23235.388 + 23819.591) / 119546.025)
=0.522097 / 0.393614
=1.3264

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-20643.683 - 0 - -15628.033) / 107298.482
=-0.046745

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

TiumBio Co has a M-score of -3.07 suggests that the company is unlikely to be a manipulator.


TiumBio Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of TiumBio Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


TiumBio Co Business Description

Traded in Other Exchanges
N/A
Address
49, Daewangpangyo-ro 644beon-gil, Bundang-gu, 4th floor, Gyeonggi, Seongnam, KOR, 13493
TiumBio Co Ltd is a Biopharmaceutical company. It is engaged in research and development of rare and intractable diseases. The company's products are in pipeline. It offers products such as Idiopathic pulmonary fibrosis therapies, immune chemotherapy, endometriosis therapies, hemophilia.

TiumBio Co Headlines

No Headlines